Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Marketing
GSK Scores High in Market Access
GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts.
The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
New FDA Campaign Targets Detailing, Trade Shows
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory Also tagged Advertising, DDMAC, Detailing, FDA, Margaret Hamburg, Professional Marketing Leave a comment
A Crash Course in SaaS
Image via Wikipedia
Our magazine is called Pharmaceutical Executive—indicating a focus on the c-suite. But we know many of our readers aren’t executives (yet), and may not have quite the same in-depth knowledge as their bosses. So, for those who hear the term “SaaS” bandied about in conversations and fake their way through discussions about it [...]
Posted in Strategy Also tagged business, cloud computing, Customer Relationship Management, Holy Grail, Pfizer, Software as a service, Veeva System Leave a comment
Webcast: SaaS or On-premise CRM—It’s Your Choice… Not Your Vendor’s
Tuesday, April 13, 2010 at 11:00 AM ET; 8:00 AM PT; 16:00 GMT
As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional ’single message to many’ approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given [...]
Posted in Webcast Also tagged business, Customer Relationship Management, Customer service, E-Commerce, Health science, Model, Sales and Marketing Productivity Leave a comment

Baxter Receives Third FDA Warning for Misleading Promotional Material